Trexquant Investment LP cut its stake in Analogic Corporation (NASDAQ:ALOG) by 72.8% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,800 shares of the medical research company’s stock after selling 10,174 shares during the period. Trexquant Investment LP’s holdings in Analogic Corporation were worth $276,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also bought and sold shares of the company. SG Americas Securities LLC acquired a new position in Analogic Corporation during the first quarter valued at $101,000. State of Alaska Department of Revenue boosted its position in Analogic Corporation by 3.0% in the first quarter. State of Alaska Department of Revenue now owns 1,380 shares of the medical research company’s stock valued at $104,000 after buying an additional 40 shares in the last quarter. US Bancorp DE boosted its position in Analogic Corporation by 59.0% in the first quarter. US Bancorp DE now owns 1,635 shares of the medical research company’s stock valued at $124,000 after buying an additional 607 shares in the last quarter. Dubuque Bank & Trust Co. acquired a new position in Analogic Corporation during the first quarter valued at $185,000. Finally, Municipal Employees Retirement System of Michigan boosted its position in Analogic Corporation by 2.5% in the first quarter. Municipal Employees Retirement System of Michigan now owns 2,850 shares of the medical research company’s stock valued at $216,000 after buying an additional 70 shares in the last quarter.
Shares of Analogic Corporation (NASDAQ:ALOG) opened at 69.50 on Friday. Analogic Corporation has a 52-week low of $66.00 and a 52-week high of $95.85. The stock’s market cap is $866.67 million. The company’s 50-day moving average price is $70.79 and its 200-day moving average price is $73.32.
Analogic Corporation (NASDAQ:ALOG) last posted its quarterly earnings data on Tuesday, June 6th. The medical research company reported $0.79 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.74 by $0.05. The firm had revenue of $122.16 million during the quarter, compared to analysts’ expectations of $121.35 million. Analogic Corporation had a positive return on equity of 6.75% and a negative net margin of 7.97%. The business’s quarterly revenue was down 4.5% on a year-over-year basis. During the same quarter last year, the firm earned $0.80 EPS. On average, equities research analysts forecast that Analogic Corporation will post $2.60 earnings per share for the current fiscal year.
Separately, Jefferies Group LLC started coverage on Analogic Corporation in a research note on Wednesday, August 9th. They issued a “hold” rating and a $75.00 price target for the company. One analyst has rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the stock. Analogic Corporation presently has a consensus rating of “Hold” and a consensus price target of $87.00.
Analogic Corporation Company Profile
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.
Want to see what other hedge funds are holding ALOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Analogic Corporation (NASDAQ:ALOG).
Receive News & Ratings for Analogic Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Corporation and related companies with MarketBeat.com's FREE daily email newsletter.